Search results

Order by most recent / most popular / relevance

Results: 1-10 of 139

Patent watch: Ass'n for Molecular Pathology v. Myriad Genetics, Inc.

A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible

After 34 years, a federal district court in Florida has overturned a 1979 injunction which prevented the Centers for Medicare and Medicaid Services

Last summer, a federal judge in Houston ruled that the Wartime Suspension of Limitations Act (WSLA), found in Title 18, 3287 of the U.S

In a ruling that may impact how professionals attempt to limit competition from alternative providers, the North Carolina State Board of Dental

A magistrate judge in the U.S. District Court for the Middle District of Florida recently ordered a hospital defendant in a False Claims Act (FCA

On May 20, 2013, in Aventis Pharms., Inc. v. Amino Chems. Ltd., the U.S. Court of Appeals for the Federal Circuit (Newman, Bryson, Reyna) reversed

On May 8, 2013, a jury in the Columbia Division of the U.S. District Court for the District of South Carolina returned a verdict finding that Tuomey

On May 1, 2013, in Allergan, Inc. v. Sandoz Inc., the U.S. Court of Appeals for the Federal Circuit (Dyk, Prost, O'Malley) affirmed-in-part and

The U.S. District Court for the Northern District of California recently denied Contra Costa Regional Medical Center's (CCRMC) motion to dismiss

On April 26, 2013, in Biosig Instruments, Inc. v. Nautilus, Inc., the U.S. Court of Appeals for the Federal Circuit (Newman, Schall, Wallach